Literature DB >> 27051062

A prognostic tool to predict severe acute pancreatitis in pediatrics.

Flora K Szabo1, Lindsey Hornung2, Judy-April Oparaji3, Rabea Alhosh4, Sohail Z Husain3, Quin Y Liu4, Joseph Palermo1, Tom K Lin1, Jaimie D Nathan5, Daniel J Podberesky6, Mark Lowe3, Lin Fei7, Maisam Abu-El-Haija8.   

Abstract

BACKGROUND/
OBJECTIVES: Approximately 15-20% of pediatric patients with acute pancreatitis (AP) develop severe disease. Severity scoring tools were developed for adult patients, but have limitations when applied in children. We aimed to identify early predictors of severe acute pancreatitis (SAP) on hospital admission for early risk stratification of patients.
METHODS: Retrospective review of AP admissions was conducted. The derivation cohort included cases at Cincinnati Children's Hospital Medical Center (CCHMC) between 2009 and 2013. Clinical data collected during the first 24 h of admission were analyzed and a predictive model was derived through statistical analysis. The performance of the model was evaluated in a validation cohort from 2 more institutions other than CCHMC.
RESULTS: In the derivation cohort 19% of the 284 admissions were SAP. A generalized linear mixed effect model analysis revealed that lipase, albumin and white blood count (WBC) play a role in the development of SAP (area under the receiver operating curve (AUROC 0.76)). In the validation cohort of 165 AP cases, SAP ranged from 8 to 20% at the three institutions. Performance of the model in this cohort was comparable to the derivation model (AUROC 0.77). There were 369 encounters in the combined derivation and validation pool (AUROC 0.76).
CONCLUSIONS: The prognostic severity tool with 3 variables (lipase, albumin, and WBC) obtained within 24 h of admission can be applied to predict SAP in pediatric patients.
Copyright © 2016 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Derivation cohort; Pediatric pancreatitis; Prognostic markers; Prognostic model; Severe acute pancreatitis; Validation cohort

Mesh:

Substances:

Year:  2016        PMID: 27051062     DOI: 10.1016/j.pan.2016.03.002

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  9 in total

Review 1.  Pancreatic Disorders.

Authors:  Aliye Uc; Douglas S Fishman
Journal:  Pediatr Clin North Am       Date:  2017-06       Impact factor: 3.278

2.  Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee.

Authors:  Maisam Abu-El-Haija; Soma Kumar; Jose Antonio Quiros; Keshawadhana Balakrishnan; Bradley Barth; Samuel Bitton; John F Eisses; Elsie Jazmin Foglio; Victor Fox; Denease Francis; Alvin Jay Freeman; Tanja Gonska; Amit S Grover; Sohail Z Husain; Rakesh Kumar; Sameer Lapsia; Tom Lin; Quin Y Liu; Asim Maqbool; Zachary M Sellers; Flora Szabo; Aliye Uc; Steven L Werlin; Veronique D Morinville
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

3.  Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Maisam Abu-El-Haija; Anna S Gukovskaya; Dana K Andersen; Timothy B Gardner; Peter Hegyi; Stephen J Pandol; Georgios I Papachristou; Ashok K Saluja; Vikesh K Singh; Aliye Uc; Bechien U Wu
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

4.  Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis-Knowledge Gaps and Research Opportunities: Overview Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Aliye Uc; Dana K Andersen; Drucy Borowitz; Marshall J Glesby; Julia Mayerle; Robert Sutton; Stephen J Pandol
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

5.  Impact of Clinical, Laboratory and Fluid Therapy Variables on Hospital Length of Stay for Children with Acute Pancreatitis.

Authors:  Abdul R Shahein; J Antonio Quiros; Ricardo A Arbizu; Candi Jump; Steven D Lauzon; Susan S Baker
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-07-03

6.  The association of parameters of body composition and laboratory markers with the severity of hypertriglyceridemia-induced pancreatitis.

Authors:  Lifang Chen; Yingbao Huang; Huajun Yu; Kehua Pan; Zhao Zhang; Yi Man; Dingyuan Hu
Journal:  Lipids Health Dis       Date:  2021-02-11       Impact factor: 3.876

7.  Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis.

Authors:  David S Vitale; Patrick Lahni; Lindsey Hornung; Tyler Thompson; Peter R Farrell; Tom K Lin; Jaimie D Nathan; Hector R Wong; Maisam Abu-El-Haija
Journal:  PLoS One       Date:  2022-02-14       Impact factor: 3.240

8.  Admission risk factors and predictors of moderate or severe pediatric acute pancreatitis: A systematic review and meta-analysis.

Authors:  Márk Félix Juhász; Zoltán Sipos; Klementina Ocskay; Péter Hegyi; Anikó Nagy; Andrea Párniczky
Journal:  Front Pediatr       Date:  2022-09-30       Impact factor: 3.569

9.  Who's at Risk? A Prognostic Model for Severity Prediction in Pediatric Acute Pancreatitis.

Authors:  Peter R Farrell; Lindsey Hornung; Peter Farmer; Angelica W DesPain; Esther Kim; Ryan Pearman; Beemnet Neway; Ashley Serrette; Sona Sehgal; James E Heubi; Tom K Lin; Jaimie D Nathan; David S Vitale; Maisam Abu-El-Haija
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-10       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.